FDA Approves Audenz as First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine

Nature’s Rx Issues Voluntary Nationwide Recall of Silver Bullet 10 Male Enhancement Capsules

Vaping Illness : FDA Warns Public to Stop Using Vaping Product

Capnocytophaga infection

Weekends cardiac arrest has fewer chances of survival

Warning about rare occurrence of serious liver injury with use of hepatitis C medicines

Givosiran approved for acute hepatic porphyria

Biotin May Interfere with Lab Tests: FDA Safety Communication

New drug for treatment-resistant forms of tuberculosis that affects the lungs

PHAF Team

© 2019 PHAF  || All rights reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.